Institutional investors purchased a net $975.3 thousand shares of RGEN during the quarter ended June 2016 and now own 90.71% of the total shares outstanding. This majority interest is a greater percentage than is typical for companies in the Biotechnology industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
CONESTOGA CAPITAL ADVISORS LLC Bought 37.2 Thousand shares of Repligen Corp
LEGAL & GENERAL INVESTMENT MANAG... Bought 22.6 Thousand shares of Repligen Corp
DANSKE BANK A/S (INVT MGMT) Bought 1.0 Thousand shares of Repligen Corp